# Safety & Immunogenicity of Pneumococcal Vaccine 2189242A in Children Aged 12-23 Months at the Time of First Vaccination

> **NCT00985751** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 257 (actual)

## Conditions studied

- Infections, Streptococcal

## Interventions

- **BIOLOGICAL:** Pneumococcal vaccine GSK2189242A (formulation 1)
- **BIOLOGICAL:** Pneumococcal vaccine GSK2189242A (formulation 2)
- **BIOLOGICAL:** Pneumococcal vaccine GSK2189242A combined with pneumococcal vaccine GSK1024850A (formulation 3)
- **BIOLOGICAL:** Pneumococcal vaccine GSK2189242A combined with pneumococcal vaccine GSK1024850A (formulation 4)
- **BIOLOGICAL:** Pneumococcal vaccine GSK1024850A

## Key facts

- **NCT ID:** NCT00985751
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11-24
- **Primary completion:** 2010-10-12
- **Final completion:** 2011-03-02
- **Target enrollment:** 257 (ACTUAL)
- **Last updated:** 2020-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00985751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00985751, "Safety & Immunogenicity of Pneumococcal Vaccine 2189242A in Children Aged 12-23 Months at the Time of First Vaccination". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00985751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*